Sign In
to Vote &
Create Storyboards.
 
Biomarker in Blood Predicts Multiple Sclerosis Progression 1 to 2 Years in Advance Researchers has found that elevated levels of NfL in the blood of multiple sclerosis (MS) patients could signal worsening disability within the next one to two years. This first-of-its-kind study pinpoints a crucial timeframe for potential interventions.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard